As we covered in detail in the the 2008 to 2010 time frame, most of what went wrong (allegedly) with Celebrex®, and Bextra®, went wrong at Pharmacia — while Fred Hassan and Carrie Cox were leading the company (prior to selling it to Pfizer — so sorry Mr. Read!). That was pre-2004. Ouch. Some of Fast Fred’s gifts never stop giving, it would seem. Here’s a bit from the Reuters story out this afternoon:
. . . .By a 3-0 vote, the 2nd U.S. Circuit Court of Appeals in Manhattan said U.S. District Judge Laura Taylor Swain erred in dismissing the case after preventing Daniel Fischel, a former University of Chicago Law School dean, from testifying for the shareholders about potential damages.
It also said Swain was wrong to conclude that jurors could not find Pfizer liable for statements by G. D. Searle & Co and Pharmacia Corp, which previously made Celebrex and Bextra, that allegedly concealed the drugs’ cardiovascular risks. . . .
Now you know. It is actually nice not to have to mention Hassan/Cox here very often any longer — Merck has moved so far beyond their befuddled chicanery. All alleged, of course. Taking a tour of the Art Institute’s new Van Gogh exhibit this afternoon — off the grid for a while. Keep it spinning in good karma one and all. . . .